Lipidemic Profile of Patients with Non-Small Cell Lung Cancer and Its Association with Driver Mutations: A Tertiary Center Retrospective Study
In this retrospective, real-world cohort, only HDL levels demonstrated a robust difference between NSCLC patients and controls. Observed associations should be interpreted cautiously due to potential confounding factors and incomplete clinical data inherent to retrospective analyses. Prospective studies are needed to clarify whether lipid alterations play a biological or prognostic role in NSCLC.
Authors
- Ioanna Marlafeka
- Fotios Sampsonas
- Dimitrios Efthymiou (ORCID: https://orcid.org/0000-0003-0979-4188)
- Vasilina Sotiropoulou (ORCID: https://orcid.org/0000-0003-2326-7149)
- Maria Lagadinou (ORCID: https://orcid.org/0000-0002-8900-0212)
- Pinelopi Bosgana (ORCID: https://orcid.org/0009-0004-3347-8403)
- Vasiliki Tzelepi (ORCID: https://orcid.org/0000-0001-6608-6183)
- Argyrios Tzouvelekis
- Emmanouil Psarros
- Prokopis Karidis
- Panagiota Tsiri
- Eirini Adamopoulou
- Ourania Papaioannou
- Markos Marangos
- Matthaios Katsaras
- Christos Michailides
Institutions
- University of Patras (GR)
- Agios Andreas Hospital (GR)
- General University Hospital of Patras (GR)
Publication Details
- Journal
- Cancers
- Published
- 2026-01-25
- DOI
- https://doi.org/10.3390/cancers18030374
- Primary Topic
- Cancer, Lipids, and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.00